Please login to the form below
Cancer diagnostics
This page shows the latest Cancer diagnostics news and features for those working in and with pharma, biotech and healthcare.
Genentech pays $30m upfront to access Bicycle Therapeutic's discovery technology
The agreement will leverage Bicycle’s proprietary bicyclic peptide technology with the aim of developing and ultimately commercialising novel treatments for cancer. ... That includes a recent alliance with Illumina on genomic testing for cancer
Latest news
-
Roche and Illumina partner on genomics for cancer diagnostics
Will leverage genomics system to match optimal cancer treatment. Roche and Illumina have announced a 15-year alliance for genomics testing, aimed at transforming cancer diagnostics. ... Roche will collaborate with Illumina to complement its comprehensive
-
$450m diagnostics sale will fuel more Syncona biotech funding
Radiopharmaceuticals firm sold to Braco Imaging. Syncona has sold off its innovative diagnostics company Blue Earth Imaging to Bracco Imaging for $450m (£354.3m). ... novel diagnostic agents such as rhPSMA and the proven success of Axumin for imaging in
-
Roche/GE’s digital medicine alliance bears first fruit
give multidisciplinary cancer care teams “a more comprehensive view of each patient in one place.”. ... cancer diagnostics based on simple blood tests – known as liquid biopsies.
-
Grail’s multi-cancer blood test gets FDA breakthrough status
Could detect multiple cancers from single blood sample. Cancer diagnostics venture GRAIL has been granted an FDA breakthrough device designation for its lead multi-cancer detecting blood test. ... However, it isn't alone in its pursuit of developing new
-
New Pfizer UK leader as Nordkamp moves into European role
Prior to this, he was Head of Pfizer Oncology in the UK where he assisted in shaping UK cancer policy through his work with government, patient groups and as a ... He also sat on the NHS Molecular Diagnostics in Cancer working group, as well as the South
More from news
Approximately 2 fully matching, plus 28 partially matching documents found.
Latest Intelligence
-
Let’s change the conversation about cancer
With new treatment approaches, survival and quality of life for cancer patients is improving. ... In the future we may move towards truly personalised cancer based on even more accurate holistic diagnostics for patients - my cancer is my own.
-
Case study: Molecular diagnostics
Together we undertook horizon- scanning to identify opportunities to make the case for molecular diagnostics; brought together key stakeholders, including Cancer Research UK and the Royal College of Pathologists, to identify ... ensure patients are
-
Diagnostics are rising up the pharma value chain
lung cancer, which was backed together with Roche Diagnostics' cobas EGFR Mutation Test. ... As evidence of this, Roche Diagnostics' collaborative work includes a deal to provide diagnostics for Boehringer's cancer portfolio.
-
Interview: John Dineen, GE Healthcare
cancer diagnostics company Clarient. ... We're working on more precise diagnostics, using Clarient and the technologies we have.
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest appointments
-
Scancell appoints Dr Cliff Holloway as CEO
Prior to this, he was chief executive officer and managing director of Sienna Cancer Diagnostics, and has held roles for Immune System Therapeutics and Biosceptre International. ... John Chiplin, executive chairman, Scancell, said: “Cliff’s extensive
-
Agendia appoints chairman of medical advisory board
Dr Hortobagyi brings over 35 years of experience in clinical and translational research of breast cancer and work as a breast medical oncologist to the molecular cancer diagnostics company. ... He currently also serves as a professor and chair Emeritus
-
Biogen's Douglas Williams departs for biotech start-up
Research head will be first member of a new cancer-focused firm. ... Douglas Williams will this week leave Biogen for a new role as CEO of an as-yet unnamed biotech start-up that will focus on cancer diagnostics and therapies.
-
Zealand Pharma appoints new CEO
Britt Meelby Jensen joins from cancer diagnostics firm Dako. Denmark-based Zealand Pharma has appointed Britt Meelby Jensen as its new CEO, effective from January 15, 2015. ... Jensen is currently CEO at Dako, which specialises in cancer diagnostics and
-
Roche appoints new oncology research head
Commenting on Pao's appointment, Reed said: "William is recognised as one of the world's leading molecular oncologists, with world class expertise in targeted cancer therapeutics, translational medicine, molecular diagnostics, ... diagnostics company,
More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.
Latest from PMHub
-
The heavy toll of COVID-19 on cancer patients
During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. ... New investments in CT scans, MRI scanners, and X-ray machines will also be required, as hospitals struggle to deal with the backlog of cancer diagnostics.
-
University spin-out fund makes half a million pound first investments
One of the first businesses to receive investment was AMLo Biosciences, a Newcastle University spin-out developing diagnostics for early-stage skin cancer.
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- Biogen and Happify Health team up to create digital platform for MS patients
- Moderna to launch Innovation and Technology Center in the UK
- Enanta takes legal action against Pfizer over Paxlovid patent infringement
- Novartis and Precision BioSciences announce in vivo gene editing collaboration
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- Live Webinar: Navigating the Nuances of Europe's MedTech Industry
- Why project managers are key to creating quality content
- Pfizer and BioNTech sign $3.2bn COVID-19 vaccine supply agreement with US government
- EMA grants Bavarian Nordic access to PRIME scheme for RSV vaccine candidate
- Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
- NICE issues final appraisal recommending LEO Pharma’s Adtralza for moderate-to-severe atopic dermatitis
- ALL SYSTEMS GO: UNDERSTANDING WHO’S WHO IN THE NEW NHS LANDSCAPE
- A creative awakening – how pharma is bringing innovation to the patient journey
- AstraZeneca’s Evusheld phase 3 results show high level of protection against COVID-19
- Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
- EMA grants Bavarian Nordic access to PRIME scheme for RSV vaccine candidate
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
PMHub
Wisepress
Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
